We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

52 hedge funds and large institutions have $702M invested in Avidity Biosciences in 2020 Q2 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67.87% more ownership

Funds ownership: 0% → 67.87% (+68%)

Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.07%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$115M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$81.7M
3
CAM
Cormorant Asset Management
Massachusetts
+$72.5M
4
EC
EcoR1 Capital
California
+$60.7M
5
PA
Perceptive Advisors
New York
+$35.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.95M +$5.05M +175,000 New
Goldman Sachs
27
Goldman Sachs
New York
$4.32M +$4.41M +152,941 New
WP
28
Woodline Partners
California
$3.53M +$3.6M +125,000 New
ACP
29
Acuta Capital Partners
California
$3.32M +$3.39M +117,500 New
Deutsche Bank
30
Deutsche Bank
Germany
$2.83M +$2.88M +100,000 New
FCM
31
Farallon Capital Management
California
$1.41M +$1.44M +50,000 New
HM
32
HealthCor Management
New York
$1.41M +$1.44M +50,000 New
PCM
33
Pinz Capital Management
New York
$1.41M +$1.44M +50,000 New
MIM
34
Monashee Investment Management
Massachusetts
$1.13M +$1.15M +40,000 New
MWNA
35
Marshall Wace North America
New York
$994K +$1.01M +35,182 New
SAM
36
Sectoral Asset Management
Quebec, Canada
$927K +$946K +32,803 New
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
$707K +$721K +25,000 New
PPA
38
Parametric Portfolio Associates
Washington
$642K +$655K +22,706 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$574K +$586K +20,309 New
CS
40
Candriam SCA
Luxembourg
$565K +$577K +20,000 New
FAM
41
Fred Alger Management
New York
$565K +$577K +20,000 New
Vanguard Group
42
Vanguard Group
Pennsylvania
$565K +$577K +20,000 New
ZP
43
Zimmer Partners
New York
$565K +$577K +20,000 New
Geode Capital Management
44
Geode Capital Management
Massachusetts
$478K +$488K +16,931 New
CCM
45
CAAS Capital Management
New York
$424K +$432K +15,000 New
PIM
46
Platinum Investment Management
Australia
$424K +$432K +15,000 New
Jane Street
47
Jane Street
New York
$401K +$409K +14,182 New
AllianceBernstein
48
AllianceBernstein
Tennessee
$283K +$288K +10,000 New
GGHC
49
Gilder Gagnon Howe & Co
New York
$283K +$288K +10,000 New
PCM
50
Pentwater Capital Management
Florida
$254K +$259K +9,000 New
1
2
3

RNAM Hedge Fund Activity: Q2 2020 in Review

52 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q2 2020, worth a combined $702M.

Buyers outnumbered sellers: 52 funds opened new RNAM positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $115M.

  • 52 institutional investors held Avidity Biosciences (RNAM) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $702M of Avidity Biosciences stock for Q2 2020.
  • 52 funds opened new Avidity Biosciences positions in Q2 2020 and 0 closed out, a net change of +52 holders.
  • The largest Avidity Biosciences buyer in Q2 2020 was RTW Investments, an estimated $115M added.

Based on aggregated 13F filings for Q2 2020.